BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Lipitor
,
rs7903146
,
SIRT1
,
Coagulation
,
Obesity
,
Breast
,
Metabolism of nitric oxide
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Hoxb4
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Loading...
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
HOXB4 inhibits the proliferation and tumorigenesis of cervical cancer cells by downregulating the ac…
Activated HoxB4-induced hematopoietic stem cells from murine pluripotent stem cells via long-term pr…
HOXB4 Promotes Hemogenic Endothelium Formation without Perturbing Endothelial Cell Development.
RNA-binding protein IGF2BP1 maintains leukemia stem cell properties by regulating HOXB4, MYB, and AL…
Mouse embryo Hox gene enhancers assayed in cell culture: Hoxb4, b8 and a7 are activated by Cdx1 prot…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Carboplatin and Nab-Paclitaxel With or Without Vorinostat in Treating Women With Newly Diagnosed Ope…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ